cgx-pgx-pharmacogenetics-cancer-testing-screening-dna-medfidence

Medfidence Targeted Medicine Overview

WE WANT YOU TO BE A PART OF THE MEDFIDENCE REVOLUTION.

Pharmacogenomics (PGx) is a key component of personalized medicine and refers to the study of genetic differences and how they influence an individual’s response to medication. These differences, also called genetic variants, can play a role in the efficacy and toxicity of medications, which can lead to serious side effects and can increase the risk of certain drug to-drug interactions. Pharmacogenetic testing can detect variants within your DNA and can give you and your healthcare provider the tools to make an informed treatment decision based on your individual genetic profile.

The following PDF is designed to give the consumer of clear understanding of the entire genetic cancer screening process.

medfidence-pgx-overview-consumer